Stifel Nicolaus Reiterates “Buy” Rating for Puma Biotechnology Inc (PBYI) – The Cerbat Gem

Posted: Published on May 5th, 2017

This post was added by Dr P. Richardson


Post Analyst
Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI)
The Cerbat Gem
Puma Biotechnology Inc logo Stifel Nicolaus reaffirmed their buy rating on shares of Puma Biotechnology Inc (NYSE:PBYI) in a report released on Wednesday, April 19th. They currently have a $88.00 target price on the biopharmaceutical company's stock.
Puma Biotechnology (PBYI) Getting Somewhat Positive Press Coverage, Report ShowsTranscript Daily
Puma Biotechnology, Inc. (PBYI) held by 19 SEC 13F Filers | Post ...Post Analyst
NJ State Employees Deferred Compensation Plan Has $341000 Position in Puma Biotechnology Inc (PBYI)Markets Daily
Chaffey Breeze -Bibeypost.com -Sports Perspectives
all 16 news articles »

Go here to see the original:
Stifel Nicolaus Reiterates "Buy" Rating for Puma Biotechnology Inc (PBYI) - The Cerbat Gem

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.